nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—Naloxone—TLR4—pancreatitis	0.0732	0.889	CrCbGaD
Methylnaltrexone—Naloxone—ALB—pancreatitis	0.00913	0.111	CrCbGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—MTNR1B—pancreatitis	0.00373	0.00407	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00372	0.00405	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—BDKRB2—pancreatitis	0.00371	0.00405	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CNR1—pancreatitis	0.00365	0.00397	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CNR2—pancreatitis	0.00364	0.00397	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—TACR1—pancreatitis	0.00364	0.00397	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCKAR—pancreatitis	0.00358	0.0039	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00349	0.00381	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.00345	0.00376	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.00343	0.00374	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.00338	0.00369	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—KNG1—pancreatitis	0.00338	0.00368	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL5—pancreatitis	0.00335	0.00365	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CCL5—pancreatitis	0.00334	0.00364	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—SCT—pancreatitis	0.00331	0.0036	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CASR—pancreatitis	0.00331	0.0036	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CX3CL1—pancreatitis	0.00324	0.00354	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL1B—pancreatitis	0.00318	0.00347	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.00318	0.00346	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—MTNR1B—pancreatitis	0.00316	0.00344	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCK—pancreatitis	0.00316	0.00344	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00314	0.00342	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—PTHLH—pancreatitis	0.00309	0.00337	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—SMO—pancreatitis	0.00309	0.00337	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CNR2—pancreatitis	0.00308	0.00335	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—TACR1—pancreatitis	0.00308	0.00335	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCKAR—pancreatitis	0.00303	0.0033	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00295	0.00322	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.0029	0.00316	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PPY—pancreatitis	0.00286	0.00312	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—SST—pancreatitis	0.00283	0.00308	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCL5—pancreatitis	0.00283	0.00308	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.00274	0.00298	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCL2—pancreatitis	0.00273	0.00297	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.00269	0.00293	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—BDKRB2—pancreatitis	0.00266	0.0029	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.00266	0.0029	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—ALDH2—pancreatitis	0.00264	0.00287	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—SMO—pancreatitis	0.00261	0.00285	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—PTHLH—pancreatitis	0.00261	0.00285	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CNR1—pancreatitis	0.00261	0.00285	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PPY—pancreatitis	0.0026	0.00283	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—GCG—pancreatitis	0.00252	0.00275	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—TGFB1—pancreatitis	0.00247	0.00269	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—KNG1—pancreatitis	0.00242	0.00264	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PPY—pancreatitis	0.00242	0.00264	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—SST—pancreatitis	0.00239	0.00261	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.00234	0.00255	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.00231	0.00252	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL2—pancreatitis	0.00231	0.00251	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—BDKRB2—pancreatitis	0.00225	0.00245	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.00225	0.00245	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—SCT—pancreatitis	0.00221	0.00241	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CASR—pancreatitis	0.00221	0.00241	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CNR1—pancreatitis	0.00221	0.00241	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PPY—pancreatitis	0.0022	0.00239	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CXCL8—pancreatitis	0.00216	0.00235	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—GCG—pancreatitis	0.00213	0.00232	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—MTNR1B—pancreatitis	0.00211	0.0023	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCK—pancreatitis	0.00211	0.0023	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—TACR1—pancreatitis	0.00206	0.00224	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CNR2—pancreatitis	0.00206	0.00224	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—KNG1—pancreatitis	0.00205	0.00223	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL5—pancreatitis	0.00202	0.00221	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCKAR—pancreatitis	0.00202	0.0022	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SCT—pancreatitis	0.00201	0.00219	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CASR—pancreatitis	0.00201	0.00219	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.00198	0.00216	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CX3CL1—pancreatitis	0.00197	0.00215	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—HRAS—pancreatitis	0.00195	0.00212	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCK—pancreatitis	0.00192	0.00209	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—MTNR1B—pancreatitis	0.00192	0.00209	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—SCT—pancreatitis	0.00187	0.00204	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CASR—pancreatitis	0.00187	0.00204	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CNR2—pancreatitis	0.00187	0.00203	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—TACR1—pancreatitis	0.00187	0.00203	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—IL6—pancreatitis	0.00186	0.00203	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCKAR—pancreatitis	0.00184	0.002	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.00183	0.002	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CXCL8—pancreatitis	0.00182	0.00199	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—CXCL8—pancreatitis	0.00182	0.00198	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HTR2A—pancreatitis	0.00178	0.00194	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—MTNR1B—pancreatitis	0.00178	0.00194	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCK—pancreatitis	0.00178	0.00194	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PTHLH—pancreatitis	0.00175	0.00191	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CNR2—pancreatitis	0.00174	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—TACR1—pancreatitis	0.00174	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PNLIP—pancreatitis	0.00171	0.00187	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL5—pancreatitis	0.00171	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCKAR—pancreatitis	0.00171	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SCT—pancreatitis	0.0017	0.00185	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CASR—pancreatitis	0.0017	0.00185	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CX3CL1—pancreatitis	0.00166	0.00181	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—MTNR1B—pancreatitis	0.00162	0.00176	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCK—pancreatitis	0.00162	0.00176	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—SST—pancreatitis	0.0016	0.00174	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PTHLH—pancreatitis	0.00159	0.00173	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SMO—pancreatitis	0.00159	0.00173	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CNR2—pancreatitis	0.00158	0.00172	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TACR1—pancreatitis	0.00158	0.00172	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCKAR—pancreatitis	0.00155	0.00169	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.00155	0.00169	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CXCL8—pancreatitis	0.00154	0.00168	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PPY—pancreatitis	0.00154	0.00167	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PPP3CA—pancreatitis	0.00151	0.00165	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HTR2A—pancreatitis	0.00151	0.00164	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—BDKRB2—pancreatitis	0.0015	0.00164	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PTHLH—pancreatitis	0.00148	0.00161	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CNR1—pancreatitis	0.00148	0.00161	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—SST—pancreatitis	0.00145	0.00158	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.00145	0.00158	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PNLIP—pancreatitis	0.00145	0.00158	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—GCG—pancreatitis	0.00143	0.00155	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL2—pancreatitis	0.00139	0.00152	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—KNG1—pancreatitis	0.00137	0.00149	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—BDKRB2—pancreatitis	0.00137	0.00149	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—SST—pancreatitis	0.00135	0.00147	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PTHLH—pancreatitis	0.00134	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SMO—pancreatitis	0.00134	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CNR1—pancreatitis	0.00134	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PPY—pancreatitis	0.0013	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GCG—pancreatitis	0.00129	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PPP3CA—pancreatitis	0.00128	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—BDKRB2—pancreatitis	0.00127	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CNR1—pancreatitis	0.00125	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—KNG1—pancreatitis	0.00124	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—SST—pancreatitis	0.00123	0.00134	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.00122	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GCG—pancreatitis	0.0012	0.00131	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SCT—pancreatitis	0.00119	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGG—pancreatitis	0.00119	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CASR—pancreatitis	0.00119	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL2—pancreatitis	0.00118	0.00128	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CX3CL1—pancreatitis	0.00116	0.00127	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—KNG1—pancreatitis	0.00116	0.00126	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—BDKRB2—pancreatitis	0.00115	0.00126	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCL5—pancreatitis	0.00114	0.00125	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CNR1—pancreatitis	0.00113	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MTNR1B—pancreatitis	0.00113	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCK—pancreatitis	0.00113	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CNR2—pancreatitis	0.0011	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—A2M—pancreatitis	0.0011	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TACR1—pancreatitis	0.0011	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CXCL8—pancreatitis	0.0011	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GCG—pancreatitis	0.00109	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCKAR—pancreatitis	0.00109	0.00118	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CTRB2—pancreatitis	0.00106	0.00116	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—KNG1—pancreatitis	0.00105	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL5—pancreatitis	0.00104	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGA—pancreatitis	0.00101	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR2A—pancreatitis	0.00101	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SCT—pancreatitis	0.001	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGG—pancreatitis	0.001	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CASR—pancreatitis	0.001	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CX3CL1—pancreatitis	0.000983	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCL5—pancreatitis	0.000967	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCK—pancreatitis	0.000957	0.00104	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MTNR1B—pancreatitis	0.000957	0.00104	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTHLH—pancreatitis	0.000938	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SMO—pancreatitis	0.000938	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—A2M—pancreatitis	0.000932	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CNR2—pancreatitis	0.000932	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TACR1—pancreatitis	0.000932	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CXCL8—pancreatitis	0.000932	0.00102	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—FDX1—pancreatitis	0.000923	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGB—pancreatitis	0.000918	0.001	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCKAR—pancreatitis	0.000917	0.000999	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR2A—pancreatitis	0.000916	0.000998	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PPP3CA—pancreatitis	0.000895	0.000975	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL5—pancreatitis	0.000878	0.000957	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADH4—pancreatitis	0.000858	0.000935	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SST—pancreatitis	0.000858	0.000935	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGA—pancreatitis	0.000853	0.000929	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR2A—pancreatitis	0.000852	0.000929	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DUSP6—pancreatitis	0.00085	0.000927	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRSS1—pancreatitis	0.000807	0.000879	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—BDKRB2—pancreatitis	0.000807	0.000879	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SMO—pancreatitis	0.000793	0.000864	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTHLH—pancreatitis	0.000793	0.000864	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CNR1—pancreatitis	0.000792	0.000863	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGB—pancreatitis	0.000776	0.000845	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR2A—pancreatitis	0.000774	0.000843	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PNLIP—pancreatitis	0.000765	0.000834	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRSS3—pancreatitis	0.000765	0.000834	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GCG—pancreatitis	0.000765	0.000833	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PPP3CA—pancreatitis	0.000756	0.000824	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KNG1—pancreatitis	0.000734	0.0008	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SST—pancreatitis	0.000725	0.00079	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DUSP6—pancreatitis	0.000719	0.000783	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL2—pancreatitis	0.000716	0.00078	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—XDH—pancreatitis	0.000686	0.000748	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—BDKRB2—pancreatitis	0.000682	0.000743	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDGFA—pancreatitis	0.000675	0.000735	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CNR1—pancreatitis	0.000669	0.000729	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GCG—pancreatitis	0.000646	0.000704	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADH1B—pancreatitis	0.00064	0.000697	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL8—pancreatitis	0.000623	0.000679	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KNG1—pancreatitis	0.00062	0.000676	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL5—pancreatitis	0.000614	0.000669	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—pancreatitis	0.000605	0.000659	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LPL—pancreatitis	0.0006	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDGFA—pancreatitis	0.00057	0.000621	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SPP1—pancreatitis	0.000568	0.000619	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL8—pancreatitis	0.000566	0.000617	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2A—pancreatitis	0.000541	0.00059	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL8—pancreatitis	0.000527	0.000574	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL5—pancreatitis	0.000519	0.000565	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLA2G1B—pancreatitis	0.00051	0.000556	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LPL—pancreatitis	0.000507	0.000553	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LEP—pancreatitis	0.000503	0.000548	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—A2M—pancreatitis	0.000493	0.000537	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SPP1—pancreatitis	0.00048	0.000523	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL8—pancreatitis	0.000478	0.000521	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2A—pancreatitis	0.000457	0.000498	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NRAS—pancreatitis	0.000454	0.000495	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALDH2—pancreatitis	0.000451	0.000491	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—INS—pancreatitis	0.00043	0.000468	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LEP—pancreatitis	0.000425	0.000463	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—pancreatitis	0.000423	0.000461	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—KRAS—pancreatitis	0.000391	0.000426	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NRAS—pancreatitis	0.000384	0.000418	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—INS—pancreatitis	0.000363	0.000396	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MDM2—pancreatitis	0.000357	0.00039	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—pancreatitis	0.000357	0.000389	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCG—pancreatitis	0.000342	0.000372	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL8—pancreatitis	0.000334	0.000364	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HRAS—pancreatitis	0.000332	0.000362	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—KRAS—pancreatitis	0.00033	0.00036	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CASP3—pancreatitis	0.00032	0.000349	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—pancreatitis	0.000318	0.000346	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MDM2—pancreatitis	0.000302	0.000329	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL8—pancreatitis	0.000282	0.000308	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HRAS—pancreatitis	0.000281	0.000306	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CASP3—pancreatitis	0.00027	0.000295	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—pancreatitis	0.000269	0.000293	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NRAS—pancreatitis	0.000268	0.000292	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPL—pancreatitis	0.000268	0.000292	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—pancreatitis	0.000249	0.000271	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KRAS—pancreatitis	0.000231	0.000251	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NRAS—pancreatitis	0.000227	0.000247	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—pancreatitis	0.000211	0.000229	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HRAS—pancreatitis	0.000196	0.000214	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPARG—pancreatitis	0.000196	0.000213	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KRAS—pancreatitis	0.000195	0.000213	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—INS—pancreatitis	0.000192	0.000209	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—pancreatitis	0.000188	0.000205	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—pancreatitis	0.000176	0.000192	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HRAS—pancreatitis	0.000166	0.000181	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—pancreatitis	0.000159	0.000173	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—pancreatitis	0.000154	0.000168	CbGpPWpGaD
